SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: SG who wrote (12774)4/10/2014 11:07:42 AM
From: Mark Buczynski  Read Replies (2) | Respond to of 13111
 
SG - first sorry to hear about your Dad. Such a shame, especially when we know PVCT could have saved his life, only a matter of time. My brother and 2 sisters-in-law have had numerous bouts of melanoma, and one has breast cancer that has metastasized to 5 major organs.

One way to look at this and any investment, and that works for me, is to look at each day or week as a brand new investment day. Look at your holdings, see if the reason you bought still stands. If not, and there is some material event that would fail the 'do I buy today?' question, then don't. If things have changed for the positive, look at holding or even adding more.

My reasoning, for PVCT at least, is I am convinced the tech works, based on my early conversations and trust level of the company. So then it is a matter of timing. But that's me and each of us is different, and have different comfort levels. I am at the point personally that I wish I had more to invest at these levels. Everything that was anticipated is falling into place at light speed recently.

Hope this helps.

Mark



To: SG who wrote (12774)4/10/2014 1:13:57 PM
From: NOREG  Respond to of 13111
 
Welcome back, I haven't left - still lurking - but I was lucky enough to make some money on the run up from .90 to 2.50, however, I 've reinvested most of my gain - hope PVCT doesn't take it all back. Sorry about your loss, it is frustrating to know PV10 could have helped, distressing that approval is taking so long.
NOREG